The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: Results >2,000 patients in 41 countries, with focus on older patients.
 
Rachel H. Giles
Honoraria - Merck KGaA
Travel, Accommodations, Expenses - Ipsen; Merck KGaA
 
Lorenzo Marconi
No Relationships to Disclose
 
Robin Martinez
Employment - Smart Patients
 
Deborah Maskens
No Relationships to Disclose
 
Karin Kastrati
No Relationships to Disclose
 
Carlos Castro
No Relationships to Disclose
 
Juan Carlo Julian Mauro
No Relationships to Disclose
 
Robert Bick
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
James Larkin
Honoraria - Bristol-Myers Squibb; Cancer Research UK; Dynavax Technologies; Eisai; GlaxoSmithKline; Incyte; iOnctura; Merck Serono; Novartis; Pfizer; Roche/Genentech; touchEXPERTS; touchIME
Consulting or Advisory Role - Apple Tree Partners; Boston Biomedical; Bristol-Myers Squibb; GlaxoSmithKline; Immunocore; Incyte; iOnctura; Iovance Biotherapeutics; Novartis; Pfizer; YKT Corporation
Research Funding - Achilles Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Immunocore (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bioevents; Bristol-Myers Squibb; British Uro-Oncology Group (BUG); ESMO; EUSA Pharma; GlaxoSmithKline; Incyte; iOnctura; Kidney Cancer Association; MedConcept; Merck Serono; National Cancer Research Institute (NCRI); Novartis; Pfizer; Pierre Fabre; Roche/Genentech; RV Mais; Syneos Health
 
Axel Bex
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Research Funding - Pfizer (Inst)
 
Eric Jonasch
Consulting or Advisory Role - aravive; Calithera Biosciences; Eisai; Exelixis; Merck; NiKang Therapeutics; Novartis; Pfizer
Research Funding - Aravive; Novartis; Peloton Therapeutics
Travel, Accommodations, Expenses - Pfizer
 
Sara Jane Maclennan
No Relationships to Disclose
 
Michael A.S. Jewett
Stock and Other Ownership Interests - Theralase
Honoraria - Pfizer
Consulting or Advisory Role - Theralase
Patents, Royalties, Other Intellectual Property - Patent filed for radiofrequency ablation device